This post is for paying subscribers only
Already have an account? Sign in.
Novo Nordisk Lowers 2025 Outlook, Names New CEO
Novo Nordisk cut its 2025 sales and profit forecast due to slower US Wegovy & Ozempic sales, hit by competition and compounded GLP-1s. Maziar Mike Doustdar is the new CEO.